Infectious Disease
Infectious Disease(传染病)
Infectious Disease 相关产品(1138)
- GC42953BMS 345541 (trifluoroacetate salt)纯度: >98.00%
BMS 345541 is a cell permeable inhibitor of the IκB kinases IKKα and IKKβ (IC50s = 4 and 0.3 μM).
- GC43060C2 Adamantanyl Globotriaosylceramide (d18:1/2:0)CAS: 261155-87-7纯度: >98.00%
C2 Adamantanyl globotriaosylceramide (AdaGb3) is a bioactive sphingolipid and water-soluble form of globotriaosylceramide that contains an adamantanyl group in place of the fatty acyl chain.
- GC43222Cefazolin-13C2,15NCAS: 2101505-58-0纯度: >95.00%
An internal standard for the quantification of cefazolin
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC42858 | Aspergillin PZ | 483305-08-4 | >98.00% | |
A fungal metabolite | ||||
| GC42860 | Aspochalasin D | 71968-02-0 | >95.00% | |
A fungal metabolite | ||||
| GC42863 | Asukamycin | 61116-33-4 | >95.00% | |
An antitumor antibiotic | ||||
| GC42880 | Avenanthramide-C methyl ester | 955382-52-2 | >90.00% | |
Inhibitor of NF-κB activation | ||||
| GC42881 | Avermectin B1a aglycone | 71828-14-3 | >95.00% | |
An aglycone form of avermectin B 1a | ||||
| GC42882 | Avermectin B1a monosaccharide | 71831-09-9 | >95.00% | |
A macrolide anthelmintic | ||||
| GC42943 | Bischloroanthrabenzoxocinone | 866022-28-8 | >99.00% | |
An inhibitor of FAS-II | ||||
| GC42953 | BMS 345541 (trifluoroacetate salt) | - | >98.00% | |
BMS 345541 is a cell permeable inhibitor of the IκB kinases IKKα and IKKβ (IC50s = 4 and 0.3 μM). | ||||
| GC42967 | Boromycin | 34524-20-4 | >98.00% | |
A boron-containing macrolide antibiotic | ||||
| GC42978 | Bromamphenicol | 17371-30-1 | >99.00% | |
A dibrominated derivative of chloramphenicol | ||||
| GC43032 | C16 Globotriaosylceramide (d18:1/16:0) | 137896-85-6 | >98.00% | |
A sphingolipid | ||||
| GC43049 | C18 Globotriaosylceramide (d18:1/18:0) | 69283-33-6 | >98.00% | |
A sphingolipid | ||||
| GC43060 | C2 Adamantanyl Globotriaosylceramide (d18:1/2:0) | 261155-87-7 | >98.00% | |
C2 Adamantanyl globotriaosylceramide (AdaGb3) is a bioactive sphingolipid and water-soluble form of globotriaosylceramide that contains an adamantanyl group in place of the fatty acyl chain. | ||||
| GC43071 | C22 Sphingomyelin (d18:1/22:0) | 94359-12-3 | - | |
A sphingolipid | ||||
| GC43131 | Calpinactam | 1205538-83-5 | >95.00% | |
A fungal metabolite | ||||
| GC43135 | Cambendazol | 26097-80-3 | >98.00% | |
An anthelmintic agent | ||||
| GC43138 | CAP 3 | 2292123-03-4 | >98.00% | |
A cholic acid-peptide conjugate with antibacterial activity | ||||
| GC43142 | Cardanol diene | 51546-63-5 | >95.00% | |
A tyrosinase inhibitor | ||||
| GC43143 | Cardanol triene | 79353-39-2 | >95.00% | |
A tyrosinase inhibitor | ||||
| GC43176 | CAY10575 | 916985-21-2 | >95.00% | |
An IKKβ and Plk1 inhibitor | ||||
| GC43196 | CAY10704 | 101784-44-5 | >98.00% | |
An inhibitor of HCV infection | ||||
| GC43197 | CAY10711 | 1666171-29-4 | >95.00% | |
A substituted diamine antibiotic | ||||
| GC43222 | Cefazolin-13C2,15N | 2101505-58-0 | >95.00% | |
An internal standard for the quantification of cefazolin | ||||
| GC43237 | Chevalone C | 1318025-77-2 | >95.00% | |
A fungal metabolite | ||||